GE completes FDA submission for breast tomosynthesis technology

07/31/2013 | AuntMinnie.com (free registration)

GE Healthcare said the final module of its premarket approval application for the GE Breast Tomosynthesis system has been forwarded to the FDA. The technology, which serves as an add-on option for the company's Senographe Essential device, delivers 3D digital images of the breast to aid in the detection of breast cancer.

View Full Article in:

AuntMinnie.com (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN